Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: Role of TGFβ/BMP-6 and TIEG1 in chemotherapy escape
Correction(s) for this article
-
Erratum
- Volume 124Issue 9International Journal of Cancer
- pages: 2250-2250
- First Published online: January 28, 2009
Guri Døsen-Dahl
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorElse Munthe
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorMarit Kveine Nygren
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorHeidi Stubberud
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorMarit E. Hystad
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorCorresponding Author
Edith Rian
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Fax: +47-22-50-07-30
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, 0310 Oslo, NorwaySearch for more papers by this authorGuri Døsen-Dahl
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorElse Munthe
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorMarit Kveine Nygren
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorHeidi Stubberud
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorMarit E. Hystad
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Search for more papers by this authorCorresponding Author
Edith Rian
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
Fax: +47-22-50-07-30
Department of Immunology, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, 0310 Oslo, NorwaySearch for more papers by this authorAbstract
The bone marrow microenvironment regulates early B lymphopoiesis and protects leukemia cells against chemotherapy treatment, thus the microenvironment may serve as a sanctuary site for these cells. Yet, few factors that contribute to this process are known. We have explored the role of transforming growth factor β (TGFβ) and bone morphogenetic protein-6 (BMP-6) and one target gene, TGFβ inducible early gene 1 (TIEG1), in the communication between stroma cells and acute lymphoblastic leukemia (ALL) cell lines and their escape from chemotherapy. Here, we have demonstrated TIEG1 expression in both normal B progenitor cells and ALL cells, which increased rapidly upon TGFβ and BMP-6 treatment. Stimulation with TGFβ or BMP-6, as well as overexpression of TIEG1 inhibited proliferation. Furthermore, interaction with stroma cells induced TIEG1 expression in ALL cells, inhibited their proliferation and protected the cells against chemotherapeutic treatment. Similarly, treatment with TGFβ or BMP-6, as well as overexpression of TIEG1, protected ALL cells against chemotherapy-induced cell death. These data suggest that TGFβ and BMP-6 in the bone marrow microenvironment allow leukemia cells to escape therapy. Further, the data indicate that TIEG1 might be involved in mediating this effect from the microenvironment onto the leukemia cells. © 2008 Wiley-Liss, Inc.
References
- 1 Hirose J,Kouro T,Igarashi H,Yokota T,Sakaguchi N,Kincade PW. A developing picture of lymphopoiesis in bone marrow. Immunol Rev 2002; 189: 28–40.
- 2 Tokoyoda K,Egawa T,Sugiyama T,Choi BI,Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004; 20: 707–18.
- 3 Torlakovic E,Tenstad E,Funderud S,Rian E. CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow. J Pathol 2005; 205: 311–17.
- 4 Wagner W,Saffrich R,Wirkner U,Eckstein V,Blake J,Ansorge A,Schwager C,Wein F,Miesala K,Ansorge W,Ho AD. Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells 2005; 23: 1180–91.
- 5 LeBien TW. Fates of human B-cell precursors. Blood 2000; 96: 9–23.
- 6 Bertrand FE,Eckfeldt CE,Fink JR,Lysholm AS,Pribyl JA,Shah N,LeBien TW. Microenvironmental influences on human B-cell development. Immunol Rev 2000; 175: 175–86.
- 7 Blom B,Spits H. Development of human lymphoid cells. Annu Rev Immunol 2006; 24: 287–320.
- 8 Gibson LF. Survival of B lineage leukemic cells: signals from the bone marrow microenvironment. Leuk Lymphoma 2002; 43: 19–27.
- 9 Pui CH,Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov 2007; 6: 149–65.
- 10 Hall BM,Gibson LF. Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules. Leuk Lymphoma 2004; 45: 35–48.
- 11 Wang L,Fortney JE,Gibson LF. Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt. Leuk Res 2004; 28: 733–42.
- 12 Wang L,Chen L,Benincosa J,Fortney J,Gibson LF. VEGF-induced phosphorylation of Bcl-2 influences B lineage leukemic cell response to apoptotic stimuli. Leukemia 2005; 19: 344–53.
- 13 Zeng Z,Samudio IJ,Munsell M,An J,Huang Z,Estey E,Andreeff M,Konopleva M. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 2006; 5: 3113–21.
- 14 Bhatia M,Bonnet D,Wu D,Murdoch B,Wrana J,Gallacher L,Dick JE. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 1999; 189: 1139–48.
- 15 Eaves CJ,Cashman JD,Kay RJ,Dougherty GJ,Otsuka T,Gaboury LA,Hogge DE,Lansdorp PM,Eaves AC,Humphries RK. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 1991; 78: 110–17.
- 16 Kawaguchi H,Kurokawa T,Hoshino Y,Kawahara H,Ogata E,Matsumoto T Immunohistochemical demonstration of bone morphogenetic protein-2 and transforming growth factor-beta in the ossification of the posterior longitudinal ligament of the cervical spine. Spine 1992; 17: S33–S36.
- 17 Centrella M,Horowitz MC,Wozney JM,McCarthy TL. Transforming growth factor-beta gene family members and bone. Endocr Rev 1994; 15: 27–39.
- 18 Kersten C,Dosen G,Myklebust JH,Sivertsen EA,Hystad ME,Smeland EB,Rian E. BMP-6 inhibits human bone marrow B lymphopoiesis–upregulation of Id1 and Id3. Exp Hematol 2006; 34: 72–81.
- 19 Tang J,Nuccie BL,Ritterman I,Liesveld JL,Abboud CN,Ryan DH. TGF-β down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. J Immunol 1997; 159: 117–25.
- 20 Buske C,Becker D,Feuring-Buske M,Hannig H,Wulf G,Schafer C,Hiddemann W,Wormann B. TGF-β inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia 1997; 11: 386–92.
- 21 Lotz M,Ranheim E,Kipps TJ. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 1994; 179: 999–1004.
- 22 Detmer K,Walker AN. Bone morphogenetic proteins act synergistically with haematopoietic cytokines in the differentiation of haematopoietic progenitors. Cytokine 2002; 17: 36–42.
- 23 Chen D,Zhao M,Harris SE,Mi Z. Signal transduction and biological functions of bone morphogenetic proteins. Front Biosci 2004; 9: 349–58.
- 24 Blok LJ,Grossmann ME,Perry JE,Tindall DJ. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Mol Endocrinol 1995; 9: 1610–20.
- 25 Bieker JJ. Kruppel-like factors: three fingers in many pies. J Biol Chem 2001; 276: 34355–8.
- 26 Dang DT,Pevsner J,Yang VW. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 2000; 32: 1103–21.
- 27 Hefferan TE,Subramaniam M,Khosla S,Riggs BL,Spelsberg TC. Cytokine-specific induction of the TGF-β inducible early gene (TIEG): regulation by specific members of the TGF-β family. J Cell Biochem 2000; 78: 380–90.
- 28 Johnsen SA,Subramaniam M,Effenberger KE,Spelsberg TC. The TGFβ inducible early gene plays a central role in the anti-proliferative response to TGFβ. Signal Transduct 2004; 4: 29–35.
- 29 Zhang Z,Wang YH,Zemlin M,Findley HW,Bridges SL,Burrows PD,Cooper MD. Molecular mechanism of serial VH gene replacement. Ann NY Acad Sci 2003; 987: 270–3.
- 30 Pribyl JAR,Shah N,Dittel BN,LeBien TW. Methods for purification and growth of human B cell precursors in bone marrow stromal cell-dependent cultures. In: I Lefkovits, ed. Immunology methods manual, 2nd edn. San Diego, CA: Academic, 1997. 903–23.
- 31 Døsen G,Tenstad E,Nygren MK,Stubberud H,Funderud S,Rian E. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis. BMC Immunol 2006; 7: 13.
- 32 Hystad ME,Myklebust JH,Bo TH,Sivertsen EA,Rian E,Forfang L,Munthe E,Rosenwald A,Chiorazzi M,Jonassen I,Staudt LM,Smeland EB. Characterization of early stages of human B cell development by gene expression profiling. J Immunol 2007; 179: 3662–71.
- 33 Patzke S,Lindeskog M,Munthe E,Aasheim HC. Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines. Virology 2002; 303: 164–73.
- 34 Hardy RR,Carmack CE,Shinton SA,Kemp JD,Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991; 173: 1213–25.
- 35 Rolink AG,Winkler T,Melchers F,Andersson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 2000; 191: 23–32.
- 36 Kee BL,Rivera RR,Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2001; 2: 242–7.
- 37
Ducos K,Panterne B,Fortunel N,Hatzfeld A,Monier MN,Hatzfeld J.
p21(cip1) mRNA is controlled by endogenous transforming growth factor-β1 in quiescent human hematopoietic stem/progenitor cells.
J Cell Physiol
2000;
184:
80–5.
10.1002/(SICI)1097-4652(200007)184:1<80::AID-JCP8>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- 38 Batard P,Monier MN,Fortunel N,Ducos K,Sansilvestri-Morel P,Phan T,Hatzfeld A,Hatzfeld JA. TGF-(β)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 2000; 113: 383–90.
- 39 Fortunel NO,Hatzfeld A,Hatzfeld JA. Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis. Blood 2000; 96: 2022–36.
- 40 Hefferan TE,Reinholz GG,Rickard DJ,Johnsen SA,Waters KM,Subramaniam M,Spelsberg TC. Overexpression of a nuclear protein. TIEG, mimics transforming growth factor-beta action in human osteoblast cells. J Biol Chem 2000; 275: 20255–9.
- 41 Mudry RE,Fortney JE,York T,Hall BM,Gibson LF. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 2000; 96: 1926–32.
- 42 Konopleva M,Andreeff M. Targeting the leukemia microenvironment. Curr Drug Targets 2007; 8: 685–701.
- 43 Jin W,Di G,Li J,Chen Y,Li W,Wu J,Cheng T,Yao M,Shao Z. TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade. FEBS Lett 2007; 581: 3826–32.
- 44 Xu Y,Tabe Y,Jin L,Watt J,McQueen T,Ohsaka A,Andreeff M,Konopleva M. TGF-β receptor kinase inhibitor LY2109761 reverses the anti-apoptotic effects of TGF-β1 in myelo-monocytic leukaemic cells co-cultured with stromal cells. Br J Haematol 2008; 142: 192–201.
- 45 Tachibana I,Imoto M,Adjei PN,Gores GJ,Subramaniam M,Spelsberg TC,Urrutia R. Overexpression of the TGFβ-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 1997; 99: 2365–74.
- 46 Alvarez-Rodriguez R,Barzi M,Berenguer J,Pons S. BMP2 opposes Shh mediated proliferation in cerebellar granule cells through a TIEG-1 based regulation of Nmyc. J Biol Chem 2007; 282: 37170–80.
- 47
Subramaniam M,Hefferan TE,Tau K,Peus D,Pittelkow M,Jalal S,Riggs BL,Roche P,Spelsberg TC.
Tissue, cell type, and breast cancer stage-specific expression of a TGF-β inducible early transcription factor gene.
J Cell Biochem
1998;
68:
226–36.
10.1002/(SICI)1097-4644(19980201)68:2<226::AID-JCB9>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- 48 Reinholz MM,An MW,Johnsen SA,Subramaniam M,Suman VJ,Ingle JN,Roche PC,Spelsberg TC. Differential gene expression of TGF β inducible early gene (TIEG). Smad7, Smad2 and. Bard1 in normal and malignant breast tissue. Breast Cancer Res Treat 2004; 86: 75–88.
- 49 Benson JR. Role of transforming growth factor beta in breast carcinogenesis. Lancet Oncol 2004; 5: 229–39.
- 50 Johnsen SA,Subramaniam M,Janknecht R,Spelsberg TC. TGFβ inducible early gene enhances TGFβ/Smad-dependent transcriptional responses. Oncogene 2002; 21: 5783–90.
- 51 Johnsen SA,Subramaniam M,Katagiri T,Janknecht R,Spelsberg TC. Transcriptional regulation of Smad2 is required for enhancement of TGFβ/Smad signaling by TGFβ inducible early gene. J Cell Biochem 2002; 87: 233–41.
- 52 Ramasamy R,Lam EW,Soeiro I,Tisato V,Bonnet D,Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 2007; 21: 304–10.
- 53 de Jonge-Peeters SD,Kuipers F,de Vries EG,Vellenga E. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Crit Rev Oncol Hematol 2007; 62: 214–26.
- 54 Ho AD,Wagner W. Bone marrow niche and leukemia. Ernst Schering Found Symp Proc 2006; 5: 125–39.